DRREDDY

Dr. Reddy's Laboratories Limited

Pharmaceuticals

Share price

₹1,233

Market cap

₹1.0L Cr

1Y return

▲ 0%

A leading India-based pharmaceutical company, Dr Reddy's Laboratories manufactures and distributes Active Pharmaceutical Ingredients, generic medicines, biosimilars, and differentiated formulations across multiple therapeutic areas. The company operates custom pharmaceutical services and serves patients in markets worldwide. Its integrated operations span drug discovery, development, manufacturing, and commercialization of innovative and generic pharmaceuticals for diverse healthcare needs.

Investors holding Dr. Reddy's Laboratories Limited

Institution

12.16%

Foreign Investor

11.41%

PPFAS Mutual Fund

Mutual Fund

1.73%

Government Pension Fund Global (Norway)

Foreign Investor

1.08%

UTI Mutual Fund

Mutual Fund

0.42%

Nippon India Mutual Fund

Mutual Fund

0.03%

SBI Mutual Fund

Mutual Fund

0.00%

ICICI Prudential Mutual Fund

Mutual Fund

0.00%

Recent moves 7

ICICI Prudential Mutual FundIncreased

ICICI Prudential Mutual Fund raised its stake in Dr. Reddy's Laboratories from 4.92% to 5.01%, buying 7,12,884 shares in an open market transaction and crossing the 5% disclosure threshold.

Nippon India Mutual FundDecreased

Nippon India Mutual Fund trimmed its stake in Dr. Reddy's Laboratories from 2.42% to 1.88%, selling 89,67,147 shares.

SBI Mutual FundDecreased

SBI Mutual Fund trimmed its stake in Dr. Reddy's Laboratories from 1.48% to 1.43%, selling 7,35,764 shares. The sold shares are valued at approximately ₹88.07 Cr at the current market price.

PPFAS Mutual FundIncreased

PPFAS Mutual Fund increased its stake in Dr. Reddy's Laboratories from 1.73% to 1.76%, buying 602,782 shares. This position is worth ₹35.79 Cr based on the company's share price of ₹1206.00.

ICICI Prudential Mutual FundIncreased

ICICI Prudential Mutual Fund raised its stake in Dr. Reddy's Laboratories Limited from 4.01% to 4.41%. The fund acquired 65,20,230 shares, increasing its holding to 7,33,85,423 shares.

JPMorganDecreased

JPMorgan decreased its stake in Dr. Reddy's Laboratories Limited from 11.94% to 11.41%. While the exact number of shares and value for this transaction are not available, other sources indicate JPMorgan sold 130,856 shares in June 2020 for ₹11.2 crore.

Government Pension Fund Global (Norway)Decreased

Government Pension Fund Global (Norway) decreased its stake in Dr. Reddy's Laboratories Limited from 1.10% to 1.08%, selling 125,428 shares.

Track the whales in Dr. Reddy's Laboratories Limited

Get alerted the moment a top investor buys or sells.